Biocept Announces Closing of $10.0 Million Underwritten Public Offering
The warrants are immediately exercisable at a price of
The offering was conducted pursuant to the Company's registration statement on Form S-1 (File No. 333-234459), as amended, previously filed with and subsequently declared effective by the
This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.
LHA Investor Relations
View original content to download multimedia:http://www.prnewswire.com/news-releases/biocept-announces-closing-of-10-0-million-underwritten-public-offering-300973763.html